Evidence map›Paper›PMID 20845910›Full record

ArticleOrganic letters2010

Tricyclic 2'-C-modified nucleosides as potential anti-HCV therapeutics.

Orrette R Wauchope, Matthew J Tomney, Joseph L Pepper, Brent E Korba, Katherine L Seley-Radtke

Abstract read
In one paragraph

Article in Organic letters, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Thiophene-expanded guanosine analogues of Gemcitabine.Bioorganic & medicinal chemistry letters · 2015
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Orrette R WauchopeDepartment of Chemistry and Biochemistry, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA.
Matthew J Tomney
Joseph L Pepper
Brent E Korba
Katherine L Seley-Radtke

Funding

Unnatural Base Pairs as DNA BioprobesR01GM073645 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE COUNTY · PI SELEY-RADTKE, KATHERINE L · 2005 to 2009
$1.1M
NIAID NIH HHS N01 AI030046NIAID NIH HHS N01-AI-30046NIGMS NIH HHS R01 GM073645NIGMS NIH HHS R01 GM076345
6 · The paper itself

Abstract

Promising biological activity in a number of therapeutic areas has been reported for both tricyclic nucleosides and 2'-modified nucleosides. In particular, disubstitution at the C-2' position of nucleosides has resulted in significant activity against the hepatitis C virus (HCV). Combining this with the observation that tricyclic nucleosides developed in our laboratory have been shown to inhibit the RNA-dependent RNA polymerase NS5B led to the design of a series of 2'-modified tricyclic nucleosides. Details of the synthesis, structural characterization, and preliminary biological results are reported.

Indexed as

Antiviral AgentsHepacivirusHeterocyclic Compounds, 3-RingMolecular StructureNucleosidesAntiviral AgentsHeterocyclic Compounds, 3-RingNucleosides

Identifiers

PMID20845910
PMCPMC2975515

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.